Mentioned On
Episode Mentions
How I Invest with David Weisburd · Apr 22, 2026
E353: Why Biotech Is Struggling in Today’s Market (and the Future of Healthcare)
“David Weisburd was a top partner for 18 years before founding his own fund Averin Capital.”
Biotech Drug Development EconomicsInflation Reduction Act Impact on Pharma PricingChina's Dominance in Drug Discovery
View Analysis